Metraipolis › archive › dc_347d3f689be5

The Prognostic Value of Biomarkers Identified by [18F]FDG-PET/CT in Patients with High-Risk Melanoma Treated with Adjuvant Immunotherapy — Europe PMC PMID:41515575

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41515575
DOI
10.3390/diagnostics16010079
License (as archived)
solo-consultazione
Archived
2026-10-07T22:21:20.636Z
SHA-256 of the archived text
d884773dfd20a8547deb8f6fee98456df6d99fb58d5356c1efc2af4dbcaa1fd2
Stable URL of this page
https://metraipolis.com/documento/dc_347d3f689be5

How to cite

The Prognostic Value of Biomarkers Identified by [18F]FDG-PET/CT in Patients with High-Risk Melanoma Treated with Adjuvant Immunotherapy — Europe PMC PMID:41515575 — Europe PMC (en), https://europepmc.org/article/MED/41515575 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_347d3f689be5 (Metraipolis archive dc_347d3f689be5, sha256 d884773dfd20a8547deb8f6fee98456df6d99fb58d5356c1efc2af4dbcaa1fd2)
BibTeX
@misc{dc347d3f689be5,
  title = {The Prognostic Value of Biomarkers Identified by [18F]FDG-PET/CT in Patients with High-Risk Melanoma Treated with Adjuvant Immunotherapy — Europe PMC PMID:41515575},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41515575},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_347d3f689be5; sha256 d884773dfd20a8547deb8f6fee98456df6d99fb58d5356c1efc2af4dbcaa1fd2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41515575. Agents can read the archived copy with the MCP tool read_document.